Showing 41 - 60 results of 61 for search 'Breast Cancer Research Foundation', query time: 0.09s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50

    Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care by Drew M Pardoll, Suzanne L Topalian

    Published 2025-01-01
    “…Groundbreaking regulatory approvals in triple-negative breast cancer, non-small cell lung cancer and melanoma will certainly be followed by additional approvals in other disease indications, as clinical and basic research are burgeoning globally in hundreds of clinical trials across dozens of cancer types. …”
    Get full text
    Article
  11. 51
  12. 52

    Wogonin effects on the efflux transporters BCRP and MRP2, explain its effectiveness in ulcerative colitis: Implications for metabolic and transport interactions by Yuanyuan Liu, Zerong Zhang, Xiaoyan Li, Qinghong Hu, Zhangyu Jiang, Jia Lv, Jiayi Xue, Dongyu Wang, Jianxiong Cao, Lingyu Li, Xiaowen Ou, Lijun Zhu, Zhongqiu Liu, Tao Su

    Published 2025-02-01
    “…The efflux transporters, breast cancer resistance protein (BCRP) and multidrug resistance-associated protein 2 (MRP2) are critical regulatory molecules within the enterohepatic triple recycling pathways. …”
    Get full text
    Article
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59

    Experience in conducting clinical trials in Cienfuegos by Olga Lidia Cuevas Pérez, Diana Rosa Fernández Ruíz, Gredsy Escandón López, Mayra Quirós Enrique, Yuleidis García Rodríguez

    Published 2018-02-01
    “…The highest percentage of research were aimed at confirming the efficacy and safety of product for the treatment of cancer. with the conduction of 30 clinical trials (46.8%) in locations as lungs, hematologic system, breast, head and neck and prostate. …”
    Get full text
    Article
  20. 60